Page last updated: 2024-11-07

4-pyridoxic acid lactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-pyridoxolactone: has chelating and antianemic activities; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151228
CHEBI ID16871
SCHEMBL ID2932229
MeSH IDM0111162

Synonyms (27)

Synonym
CHEBI:16871 ,
7-hydroxy-6-methylfuro[3,4-c]pyridin-1(3h)-one
.beta.-pyracin
96760-51-9
7-hydroxy-6-methyl-3h-furo[3,4-d]pyridin-1-one
furo[3,4-c]pyridin-1(3h)-one, 7-hydroxy-6-methyl-
furo(3,4-c)pyridin-1(3h)-one, 7-hydroxy-6-methyl-
4-pyridoxic acid lactone
4753-19-9
C00971 ,
4-pyridoxolactone
7-hydroxy-6-methyl-3h-furo[3,4-c]pyridin-1-one
y53bc7v3fd ,
unii-y53bc7v3fd
4pl ,
SCHEMBL2932229
7-hydroxy-6-methylfuro[3,4-c]pyridin-1(3h)-one #
4-pyridinecarboxylic acid, 3-hydroxy-5-(hydroxymethyl)-2-methyl-, .gamma.-lactone
HHPDVQLBYQFYFA-UHFFFAOYSA-N
.beta.-pyracine
7-hydroxy-6-methyl-1h,3h-furo[3,4-c]pyridin-1-one
DTXSID60197187
4-pyridoxolactone, >=98.5% (hplc)
beta-pyracin
furo[3,4-c]pyridin-1(3h)-one,7-hydroxy-6-methyl-
Q27102121
7-hydroxy-6-methylfuro(3,4-c)pyridin-1(3h)-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
lactoneAny cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
furopyridineAn organic heterobicyclic compound whose skeleton consists of a furan ring ortho-fused to a pyridine ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
vitamin B6 degradation1029

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.14 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]